Migraine is a complex neurological medicial condition characterized by a severe headache. The headache is often accompanied by nausea, vomiting, and extreme sensitivity to light and sound. Given their hormonal fluctuation, women are more susceptible to have migraine than men. Anti-migraine drugs are the therapeutic agents to be used against migraine. Treatment includes painkillers, anti-inflammatory painkillers, anti-sickness medicines, and triptan medicines.
Analysts forecast the Global Migraine Drugs market to grow at a CAGR of 3.54 percent over the period 2014-2019.
The report covers the present scenario and the growth prospects of the Global Migraine Drugs market for the period 2015-2019. The Global Migraine Drugs market can be divided into two segments: Selective Serotonin Receptor (5- HTI) Agonists/ Triptans and Ergot Alkaloids. To calculate the market size, the report considers the revenue generated from the sales of various drugs used in the treatment and prevention of migraine that are available in the market.
Global Migraine Drugs Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, the APAC region, and the EMEA region; it also covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
- Impax Laboratories
Other Prominent Vendors
- Boehringer Ingelheim
- Eli Lilly
- IntelGenx Technologies
- Johnson & Johnson
- RedHill Biopharma
- Increase in Prevalence of Migraine
- High Cost of Drugs
- Increase in Strategic Collaborations
Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Have any Query on the Report get your Queries Resolved at http://www.sandlerresearch.org/inquire-before-buying?rname=31106 .
(Prices start at US $3000 for a single user PDF)
Scars are treated using both invasive techniques such as surgery and non-invasive techniques such as OTC treatment products. These products and procedures are used to treat all types of scars, such as keloid scars, contracture scars, hypertrophic scars, and atrophic scars. Scars caused by surgery can be removed by surgical revisions, although most people are reluctant to go for another invasive procedure after a surgery. Apart from the easily available OTC scar treatment products, patients can also opt for less-known alternatives such as cryotherapy, clinical peel, and compression.
A generic drug is a duplicate of brand-name drugs and has the same dosage form, active ingredient(s), potency, route of administration, quality, and intended use as that of branded drugs. Generic drugs enter the market once the patent protection of the original developer expires. Generally, the cost of generic drugs is 50-70 percent lower than that of their brand-name counterparts, while meeting the very same standards of safety, quality, and efficacy as the innovator drugs.